Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

A Miami-Dade County woman was arrested for allegedly selling unlicensed weight-loss medications from her beauty business, ...

Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...